Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Automated Direct-to-Vial Concentration System

Published: Wednesday, June 26, 2013
Last Updated: Wednesday, June 26, 2013
Bookmark and Share
SampleGenie technology lowers labour costs and improves data reliability.

A series of technical papers are available from Genevac that demonstrate the advantages and benefits that their proprietary SampleGenie technology offers to chemical, environmental and food labs tasked with pooling and concentrating GC and HPLC fractions.

Traditional protocols for concentration of GC or HPLC fractions has involved drying multiple fractions in an evaporator, re-suspending pooled fractions into a single vial and then re-drying before storage and analysis.

Even with modern centrifugal evaporators such processes typically take 2-3 days to complete.

The development of SampleGenie™ technology enables samples in Genevac evaporators to be concentrated, without loss of volatile components, directly into a single GC or HPLC vial eliminating the need for reformatting of samples after drying.

This, and the automation offered by Genevac evaporators simplifies the protocol to a single overnight drying step before storage and analysis.

Not only does SampleGenie remove time consuming manual steps - it lowers labour costs and improves data reliability.

A series of technical papers demonstrating the advantages and benefits that SampleGenie technology offers may be downloaded from www.evaporatorinfo.com/info1.htm.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genevac Consolidate German Evaporator & Freeze Dryer Operations
Company appoints LMS as the exclusive German distributor for its market leading evaporator systems.
Wednesday, April 22, 2015
Genevac Introduces Guide to Evaporation
Genevac, a world leader in solvent removal technologies, has released a new 24-page guide ‘Introduction to Evaporation’.
Tuesday, February 24, 2015
Genevac Consolidate Evaporator & Freeze Dryer Sales Channels in the UK
Company appoints BioPharma Process Systems as exclusive UK distributor.
Thursday, May 15, 2014
GenVec Announces Manufacturing Agreement for TNFerade™
The agreement will cover technology transfer, scale-up, and validation of the manufacturing process for TNFerade through cGMP consistency lots.
Friday, January 25, 2008
Genevac Launches new Information-rich Website
According to Genevac its new website is an information hub for evaporation, concentration and lyophilization.
Tuesday, November 27, 2007
Genevac Ltd. Acquired by Riverlake Partners
The acquisition of Genevac from Thermo Scientific will play a critical role in Riverlake's SP Industries for future growth and expansion.
Friday, April 13, 2007
Genevac Installs miVac DNA Concentrator at University of Sheffield
The miVac DNA concentrator will both aid laboratory productivity and ensure samples are prepared safely at the Centre.
Thursday, April 27, 2006
New Approach to Compound Library Maintenance
The report describes a new high throughput process to produce compound libraries as dry films that have been validated for long-term storage.
Thursday, April 06, 2006
Genevac Moves on WEEE Compliance
As a result of upgrade and trade-in schemes over the last year, Genevac took back and has recycled 150 evaporators.
Tuesday, March 21, 2006
High-throughput Evaporation of Strongly Acidic Chemicals
The new version of the HT-12 Series II system has been introduced to provide laboratories with a highly efficient and safe means of routinely removing strongly acidic chemicals from their samples.
Thursday, July 14, 2005
Genevac enhance the HT-12

Thursday, July 04, 2002
Genevac DD- 4 & Metz Syn10 on Display at Labautomation 2002

Monday, January 14, 2002
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!